StocksMedium•21 October 2026•
1 min read
Thermo Fisher Scientific Revenue Grows 9% to $12.14 Billion in Q3
Key Facts
1Third quarter revenue grew 9% to $12.14 billion.
2Adjusted EPS grew 15% to $6.68.
3GAAP diluted earnings per share grew 9% to $4.64.
Thermo Fisher Scientific revenue grew 9% to $12.14 billion for the third quarter ended September 26, 2026. Business Wire reported that adjusted earnings per share increased 15% to $6.68, while GAAP diluted earnings per share rose 9% to reach $4.64.
TMO closed at $687.37 on October 20, 2026, ahead of the financial results release which indicated sustained growth in the healthcare sector. The stock traded between a low of $679.32 and a high of $693.37 during the October 20, 2026 session.